UTHR
$524.28-2.72 (-0.52%)
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally....
Recent News
Two Biotech Stocks Hover Near Highs; Natural Gas And Finance Names Show Resilience
Two biotech stocks, Ligand Pharmaceuticals and United Therapeutics, are showing resilient action in Friday's stock market.
2 Mid-Cap Stocks for Long-Term Investors and 1 We Avoid
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract significant competition, spanning from industry behemoths with seemingly infinite resources to small, nimble players with chips on their shoulders.
1 Cash-Heavy Stock to Target This Week and 2 That Underwhelm
A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining market share, or limited scalability.
CPRX vs. UTHR: Which Stock Is the Better Value Option?
CPRX vs. UTHR: Which Stock Is the Better Value Option?
This Biotech Stock Surged 75% Last Quarter and Pulled a New $9 Million Investment
Vera Therapeutics develops clinical-stage therapies for serious immunological diseases, with a lead candidate targeting kidney disorders.